Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results67% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
P 2 (1)
P 3 (1)

Trial Status

Unknown3
Completed2
Terminated1
Active Not Recruiting1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (7)

Research Network

Activity Timeline